"MAINZ, Germany, December 31, 2020 — BioNTech SE (Nasdaq: BNTX) today wants to express its thanks and gratitude not only to its employees but also to the many partners who have assisted the company in successfully developing a vaccine for COVID-19. BioNTech acknowledges that without the tireless effort from its’ employees and partners, who have played a pivotal role in this effort, it would not have been able to achieve this historic company milestone, a journey which only began in early 2020. Data from its Phase 3 study have demonstrated that the vaccine is well-tolerated and 95% effective in preventing COVID-19. The vaccine has already received conditional marketing authorizations as well as emergency use authorizations in more than 45 countries around the world, including the United States and the European Union ...
... BioNTech’s management and employees appreciate the relentlessly support of many companies. A full list of BioNTech’s partners supporting the COVID-19 project can be found below and at this link."
Bildquelle: © BioNTech SE 2020, all rights reserved